ALDX Forecast and Technical Stock Analysis
Sell candidate since 2019-12-03 Gain 1.48% PDF
Aldeyra Therapeutics fell by -3.48% in the last day ( Friday, 13th Dec 2019 ) from $5.32 to $5.14 and has now fallen 3 days in a row. During the day the stock fluctuated 6.46% from a day low at $5.11 to a day high of $5.44. The price has fallen in 6 of the last 10 days and is down by -35.65% for this period. Volume has increased in the last day by 17 926 shares but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 235 459 shares bought and sold for approximately $1.21 million.
- 30 day high of the ALDX stock price was $8.05 and low was $4.48.
- 90 day high was $8.05 and low was $4.48.
- 52 week high for Aldeyra Therapeutics - $12.79 and low - $4.31.
Aldeyra Therapeutics lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. A break down the bottom trend line at $4.75 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 3.27% during the next 3 months and, with 90% probability hold a price between $4.91 and $8.28 at the end of this period.
There are few to none technical positive signals at the moment. Aldeyra Therapeutics holds a buy signal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $5.89. On a fall, the stock will find some support from the short-term average at $5.04. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. A sales signal was issued from a pivot top point on Wednesday December 11, 2019, which indicates further falls until a new bottom pivot has been found. Aldeyra Therapeutics gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 80 ]
RSI14 is 42 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Aldeyra Therapeutics finds support from accumulated volume at $5.06.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.33 between high and low, or 6.46%. For the last week, the stock has had a daily average volatility of 6.09%.
Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.
6.09 %Average volatility
Very Low Low Medium High Very High
|ALDX $5.14 ($-0.19 -3.48%)|
ALDX is down $0.19 today, but where's it headed in 2020?
|Zacks Investment Research is releasing its prediction for ALDX based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ALDX analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!